NAMS Menopause e-Consult Features Commentary on Midlife-Related Clinical Issues
Posted on September 12, 2018
The North American Menopause Society's September issue of Menopause e-Consult features expert commentary from Dr. Heather Hirsch on midlife-related clinical issues.
► Question: After she recently screened positive for BRCA2 mutation, a 42-year-old woman in my practice underwent risk-reducing salpingo-oophorectomy (RRSO). Now that she is postmenopausal, she suffers from significant night sweats, poor sleep, and vaginal dryness. She has tried over-the-counter lubricants with no relief. She then opted to try a low-dose selective serotonin reuptake inhibitor for hot flash relief, but this did not resolve her symptoms. What is the role of hormone therapy (HT) in symptomatic postmenopausal BRCA carriers without known cancer who have had RRSO?